Investigators evaluated eGFR slope with belimumab among patients with proliferative lupus nephritis and MMF induction in the BLISS-LN trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results